RE: Article14 Jun 2026 15:51
This is positivr news for IMM holders imo.... We now have a peer reviewed paper in Autophagy, a proper recognised journal, giving more weight to P140 as an immunonormaliser.
That is the key point here. Not just company BS, but independent science backing the mechanism IMM has patented. P140 appears to correct abnormal immune/autophagy activity rather than just suppress the immune system. That is the sort of validation big pharma will be after when doing due diligence. This strengthens the whole P140 story considerably. Very positive.